A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KRP-A218 in Healthy Subjects

NCT04908800 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: KRP-A218
DRUG: Placebo
DRUG: itraconazole

Sponsor

Kyorin Pharmaceutical Co.,Ltd